#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15210	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2106	717.5	0	.	n	.	0	C1450T	SNP	1450	1450	C	1706	1706	T	790	T,C	444,299	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15210	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2106	717.5	1	SNP	n	C1184T	0	.	.	1184	1184	C	1440	1440	C	862	C	808	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15210	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2106	717.5	0	HET	.	.	.	C223T	.	223	223	C	479	479	C	885	C,T	700,106	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28742	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3541	808.3	0	.	n	.	0	T695C	SNP	695	695	T	1069	1069	C	926	C,T,G	865,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28742	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3541	808.3	0	.	n	.	0	T1971C	SNP	1971	1971	T	2345	2345	C	889	C	810	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28742	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3541	808.3	1	SNP	n	A2045G	0	.	.	2045	2045	A	2419	2419	A	846	A	808	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28742	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3541	808.3	1	SNP	n	C2597T	0	.	.	2597	2597	C	2971	2971	C	897	C	839	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28742	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3541	808.3	0	HET	.	.	.	G1337A	.	1337	1337	G	1711	1711	G	1004	G,A	573,349	.	.
folP.WHO_L_00516	folP.WHO_L_00516	1	1	27	2104	folP	855	855	100.0	folP.l15.c4.ctg.1	1474	141.8	1	SNP	p	R229S	0	.	.	685	687	CGC	981	983	CGC	213;210;211	C,A;G;C	197,1;196;197	folP.WHO_L_00516:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	155	5668	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3286	171.7	1	SNP	p	S91F	0	.	.	271	273	TCC	565	567	TCC	174;174;176	T;C;C	149;154;156	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	155	5668	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3286	171.7	1	SNP	p	D95G	0	.	.	283	285	GAC	577	579	GAC	180;181;181	G;A;C	157;159;158	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	155	5668	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3286	171.7	1	SNP	p	D95N	0	.	.	283	285	GAC	577	579	GAC	180;181;181	G;A;C	157;159;158	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_U_01459	mtrR.WHO_U_01459	1	1	667	1720	mtrR	633	633	99.84	mtrR.l15.c4.ctg.1	1299	131.5	0	.	p	.	0	D79N	NONSYN	235	237	GAT	512	514	AAT	206;203;203	A;A;T	192;189;187	.	.
mtrR.WHO_U_01459	mtrR.WHO_U_01459	1	1	667	1720	mtrR	633	633	99.84	mtrR.l15.c4.ctg.1	1299	131.5	1	SNP	p	G45D	0	.	.	133	135	GGC	410	412	GGC	213;210;212	G;G;C	200;195;197	mtrR.WHO_U_01459:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR.WHO_U_01459	mtrR.WHO_U_01459	1	1	667	1720	mtrR	633	633	99.84	mtrR.l15.c4.ctg.1	1299	131.5	0	HET	.	.	.	C95G	.	95	95	C	372	372	C	216	C,G	135,62	.	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	928	mtrR_promoter	250	250	100.0	mtrR_promoter.l6.c30.ctg.1	1047	88.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	129	5274	parC	2304	869	100.0	parC.l15.c30.ctg.1	1124	178.5	0	HET	.	.	.	G1786A	.	1786	1786	G	351	351	G	217	G,A	87,106	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	129	5274	parC	2304	1423	99.72	parC.l15.c30.ctg.2	1628	192.3	1	SNP	p	D86N	0	.	.	256	258	GAC	461	463	GAC	207;205;205	G;A;C	195;189;192	parC.WHO_F_01444:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	129	5274	parC	2304	1423	99.72	parC.l15.c30.ctg.2	1628	192.3	1	SNP	p	S87R	0	.	.	259	261	AGT	464	466	AGT	204;203;205	A;G;T	190;192;191	parC.WHO_F_01444:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	129	5274	parC	2304	1423	99.72	parC.l15.c30.ctg.2	1628	192.3	1	SNP	p	S87W	0	.	.	259	261	AGT	464	466	AGT	204;203;205	A;G;T	190;192;191	parC.WHO_F_01444:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	129	5274	parC	2304	1423	99.72	parC.l15.c30.ctg.2	1628	192.3	1	SNP	p	S87I	0	.	.	259	261	AGT	464	466	AGT	204;203;205	A;G;T	190;192;191	parC.WHO_F_01444:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	129	5274	parC	2304	1423	99.72	parC.l15.c30.ctg.2	1628	192.3	1	SNP	p	S88P	0	.	.	262	264	TCC	467	469	TCC	209;209;209	T;C;C	197;195;196	parC.WHO_F_01444:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	129	5274	parC	2304	1423	99.72	parC.l15.c30.ctg.2	1628	192.3	0	HET	.	.	.	G1150A	.	1150	1150	G	1355	1355	G	240	G,A	138,80	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	129	5274	parC	2304	1423	99.72	parC.l15.c30.ctg.2	1628	192.3	0	HET	.	.	.	T1304C,G	.	1304	1304	T	1509	1509	T	212	T,C,G	121,68,1	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	129	5274	parC	2304	1423	99.72	parC.l15.c30.ctg.2	1628	192.3	0	HET	.	.	.	G1305A	.	1305	1305	G	1510	1510	G	213	G,A	123,68	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	129	5274	parC	2304	1423	99.72	parC.l15.c30.ctg.2	1628	192.3	0	HET	.	.	.	C819T	.	819	819	C	1024	1024	C	190	C,T	113,62	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	667	4444	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2746	161.1	0	.	p	.	0	V89A	NONSYN	265	267	GTC	603	605	GCC	201;199;203	G,C;C,T;C	184,1;123,60;183	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	667	4444	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2746	161.1	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1566	1568	GGC	215;210;209	G;G;C	196;190;186	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	667	4444	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2746	161.1	0	HET	.	.	.	T930C	.	930	930	T	1268	1268	T	222	T,C	83,117	.	.
penA.15.001	penA.15.001	1	1	155	4010	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2274	174.7	1	SNP	p	A311V	0	.	.	931	933	GCA	1275	1277	GCA	219;218;214	G;C;A	192;188;187	penA.15.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.15.001	penA.15.001	1	1	155	4010	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2274	174.7	1	SNP	p	I312M	0	.	.	934	936	ATC	1278	1280	ATC	217;216;216	A;T,C;C	192;188,1;186	penA.15.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.15.001	penA.15.001	1	1	155	4010	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2274	174.7	1	SNP	p	V316P	0	.	.	946	948	GTG	1290	1292	GTG	210;211;214	G,A;T;G	186,1;185;185	penA.15.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.15.001	penA.15.001	1	1	155	4010	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2274	174.7	1	SNP	p	V316T	0	.	.	946	948	GTG	1290	1292	GTG	210;211;214	G,A;T;G	186,1;185;185	penA.15.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.15.001	penA.15.001	1	1	155	4010	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2274	174.7	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1791	1793	ACC	212;211;212	A;C;C	188;190;192	penA.15.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.15.001	penA.15.001	1	1	155	4010	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2274	174.7	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1845	1847	GCG	212;213;215	G;C;G	170;163;165	penA.15.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.15.001	penA.15.001	1	1	155	4010	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2274	174.7	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1845	1847	GCG	212;213;215	G;C;G	170;163;165	penA.15.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.15.001	penA.15.001	1	1	155	4010	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2274	174.7	1	SNP	p	G542S	0	.	.	1624	1626	GGC	1968	1970	GGC	194;190;187	G;G,C;C	175;171,1;172	penA.15.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.15.001	penA.15.001	1	1	155	4010	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2274	174.7	1	SNP	p	G545S	0	.	.	1633	1635	GGC	1977	1979	GGC	179;177;178	G;G;C	165;162;163	penA.15.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.15.001	penA.15.001	1	1	155	4010	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2274	174.7	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1995	1997	CCG	169;168;166	C,G;C,T;G	135,3;82,51;132	penA.15.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.15.001	penA.15.001	1	1	155	4010	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2274	174.7	0	HET	.	.	.	G1034GCGA,GCGACGA	.	1034	1034	G	1378	1378	G	219	GCGA,GCGACGA	146,60	.	.
penA.15.001	penA.15.001	1	1	155	4010	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2274	174.7	0	HET	.	.	.	C1547G	.	1547	1547	C	1891	1891	C	215	C,G	118,78	.	.
penA.15.001	penA.15.001	1	1	155	4010	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2274	174.7	0	HET	.	.	.	C1518T	.	1518	1518	C	1862	1862	C	200	C,T	118,58	.	.
penA.15.001	penA.15.001	1	1	155	4010	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2274	174.7	0	HET	.	.	.	C1551G	.	1551	1551	C	1895	1895	C	221	C,G	125,79	.	.
penA.15.001	penA.15.001	1	1	155	4010	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2274	174.7	0	HET	.	.	.	G1521C	.	1521	1521	G	1865	1865	G	197	G,C	123,58	.	.
penA.15.001	penA.15.001	1	1	155	4010	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2274	174.7	0	HET	.	.	.	C1713A,T	.	1713	1713	C	2057	2057	C	174	C,A,T	93,71,1	.	.
penA.15.001	penA.15.001	1	1	155	4010	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2274	174.7	0	HET	.	.	.	T1524C,G	.	1524	1524	T	1868	1868	T	197	T,C,G	120,61,2	.	.
penA.15.001	penA.15.001	1	1	155	4010	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2274	174.7	0	HET	.	.	.	T1269C	.	1269	1269	T	1613	1613	T	193	T,C	112,71	.	.
penA.15.001	penA.15.001	1	1	155	4010	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2274	174.7	0	HET	.	.	.	A1621C	.	1621	1621	A	1965	1965	A	190	A,C	101,71	.	.
penA.15.001	penA.15.001	1	1	155	4010	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2274	174.7	0	HET	.	.	.	T1719C	.	1719	1719	T	2063	2063	T	169	T,C	91,70	.	.
penA.15.001	penA.15.001	1	1	155	4010	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2274	174.7	0	HET	.	.	.	C1497T	.	1497	1497	C	1841	1841	C	204	C,T	93,56	.	.
penA.15.001	penA.15.001	1	1	155	4010	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2274	174.7	0	HET	.	.	.	C1529T	.	1529	1529	C	1873	1873	C	201	C,T	128,60	.	.
penA.15.001	penA.15.001	1	1	155	4010	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2274	174.7	0	HET	.	.	.	C1530G	.	1530	1530	C	1874	1874	C	202	C,G	130,59	.	.
penA.15.001	penA.15.001	1	1	155	4010	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2274	174.7	0	HET	.	.	.	G1509A	.	1509	1509	G	1853	1853	G	199	G,A	111,55	.	.
penA.15.001	penA.15.001	1	1	155	4010	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2274	174.7	0	HET	.	.	.	T1510C	.	1510	1510	T	1854	1854	T	201	T,C	113,55	.	.
penA.15.001	penA.15.001	1	1	155	4010	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2274	174.7	0	HET	.	.	.	C1512G	.	1512	1512	C	1856	1856	C	197	C,G	113,54	.	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	155	5988	ponA	2397	2397	99.92	ponA.l6.c17.ctg.1	3042	195.0	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1710	1712	CTG	203;199;206	C;T,C;G	181;121,62;190	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	659	2364	porA	1146	1146	99.83	porA.l6.c30.ctg.1	1957	120.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	616	616	C	179	C	159	.	.
porA.NCCP11945	porA.NCCP11945	1	0	659	2364	porA	1146	1146	99.83	porA.l6.c30.ctg.1	1957	120.4	0	HET	.	.	.	A64G	.	64	64	A	434	434	A	158	A,G	92,53	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	378	porB1a	984	188	91.15	porB1a.l6.c30.ctg.3	271	2.2	0	.	p	.	0	H217N	NONSYN	649	651	CAT	100	102	AAT	1;ND;ND	A;ND;ND	1;ND;ND	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	378	porB1a	984	188	91.15	porB1a.l6.c30.ctg.3	271	2.2	0	.	p	.	0	D218N	NONSYN	652	654	GAT	103	105	AAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	378	porB1a	984	188	91.15	porB1a.l6.c30.ctg.3	271	2.2	0	.	p	.	0	A222V	NONSYN	664	666	GCT	115	117	GTT	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	378	porB1a	984	188	91.15	porB1a.l6.c30.ctg.3	271	2.2	0	.	p	.	0	V226A	NONSYN	676	678	GTA	127	129	GCA	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	378	porB1a	984	188	91.15	porB1a.l6.c30.ctg.3	271	2.2	0	.	p	.	0	.	MULTIPLE	700	702	ACT	150	152	GTA	1;1;1	G;T;A	1;1;1	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	378	porB1a	984	188	91.15	porB1a.l6.c30.ctg.3	271	2.2	0	.	p	.	0	N237fs	FSHIFT	709	709	A	159	159	A	1	A	1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	645	2988	porB1b	1035	630	97.3	porB1b.l15.c30.ctg.1	834	199.6	0	.	p	.	0	T89S	NONSYN	265	267	ACC	469	471	AGC	254;249;252	A;G,C;C	224;156,71;226	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	645	2988	porB1b	1035	630	97.3	porB1b.l15.c30.ctg.1	834	199.6	0	.	p	.	0	V109A	NONSYN	325	327	GTC	529	531	GCC	249;250;251	G;C;C,T	227;230;230,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	645	2988	porB1b	1035	630	97.3	porB1b.l15.c30.ctg.1	834	199.6	0	.	p	.	0	A121S	NONSYN	361	363	GCC	565	567	AGC	214;213;218	A,G;G,C;C	139,64;139,64;202	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	645	2988	porB1b	1035	630	97.3	porB1b.l15.c30.ctg.1	834	199.6	0	.	p	.	0	N122K	NONSYN	364	366	AAC	568	570	AAA	216;216;214	A;A;A,C	200;200;135,65	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	645	2988	porB1b	1035	630	97.3	porB1b.l15.c30.ctg.1	834	199.6	0	.	p	.	0	R143E	NONSYN	427	429	AGA	631	633	GAA	247;250;257	G,C;A;A	137,89;226;232	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	645	2988	porB1b	1035	630	97.3	porB1b.l15.c30.ctg.1	834	199.6	0	.	p	.	0	R187Q	NONSYN	559	561	CGA	763	765	CAA	144;145;146	C;A;A	130;129;133	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	645	2988	porB1b	1035	630	97.3	porB1b.l15.c30.ctg.1	834	199.6	0	.	p	.	0	G189S	NONSYN	565	567	GGC	769	771	AGC	142;141;139	A;G;C	127;127;126	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	645	2988	porB1b	1035	630	97.3	porB1b.l15.c30.ctg.1	834	199.6	0	.	p	.	0	I209M	NONSYN	625	627	ATC	829	831	ATG	77;77;69	A;T;G,C	65;65;48,2	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	645	2988	porB1b	1035	630	97.3	porB1b.l15.c30.ctg.1	834	199.6	0	HET	.	.	.	C53T	.	53	53	C	257	257	C	287	C,T	171,91	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	645	2988	porB1b	1035	630	97.3	porB1b.l15.c30.ctg.1	834	199.6	0	HET	.	.	.	C315T	.	315	315	C	519	519	C	243	C,T	146,72	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	645	2988	porB1b	1035	630	97.3	porB1b.l15.c30.ctg.1	834	199.6	0	HET	.	.	.	T63C	.	63	63	T	267	267	T	289	T,C	176,88	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	645	2988	porB1b	1035	630	97.3	porB1b.l15.c30.ctg.1	834	199.6	0	HET	.	.	.	C452T	.	452	452	C	656	656	C	255	C,T	145,88	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	645	2988	porB1b	1035	630	97.3	porB1b.l15.c30.ctg.1	834	199.6	0	HET	.	.	.	C75T	.	75	75	C	279	279	C	277	C,T	165,90	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	645	2988	porB1b	1035	630	97.3	porB1b.l15.c30.ctg.1	834	199.6	0	HET	.	.	.	C587T	.	587	587	C	791	791	C	115	C,T	78,28	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	645	2988	porB1b	1035	630	97.3	porB1b.l15.c30.ctg.1	834	199.6	0	HET	.	.	.	C118CGGG,CGGGG	.	118	118	C	322	322	C	240	CGGG,CGGGG	167,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	645	2988	porB1b	1035	630	97.3	porB1b.l15.c30.ctg.1	834	199.6	0	HET	.	.	.	G119C,A	.	119	119	G	323	323	G	239	G,C,A	168,61,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	645	2988	porB1b	1035	630	97.3	porB1b.l15.c30.ctg.1	834	199.6	0	HET	.	.	.	G120A	.	120	120	G	324	324	G	242	G,A	171,60	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	645	2988	porB1b	1035	630	97.3	porB1b.l15.c30.ctg.1	834	199.6	0	HET	.	.	.	A123C	.	123	123	A	327	327	A	241	A,C	167,60	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	645	2988	porB1b	1035	630	97.3	porB1b.l15.c30.ctg.1	834	199.6	0	HET	.	.	.	A129G	.	129	129	A	333	333	A	240	A,G	168,61	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	645	2988	porB1b	1035	630	97.3	porB1b.l15.c30.ctg.1	834	199.6	0	HET	.	.	.	G133A	.	133	133	G	337	337	G	238	G,A	167,61	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	645	2988	porB1b	1035	630	97.3	porB1b.l15.c30.ctg.1	834	199.6	0	HET	.	.	.	T134G	.	134	134	T	338	338	T	237	T,G	164,61	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	645	2988	porB1b	1035	630	97.3	porB1b.l15.c30.ctg.1	834	199.6	0	HET	.	.	.	G136A	.	136	136	G	340	340	G	242	G,A	169,61	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	645	2988	porB1b	1035	630	97.3	porB1b.l15.c30.ctg.1	834	199.6	0	HET	.	.	.	G137A	.	137	137	G	341	341	G	242	G,A	169,61	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	645	2988	porB1b	1035	630	97.3	porB1b.l15.c30.ctg.1	834	199.6	0	HET	.	.	.	C138A	.	138	138	C	342	342	C	240	C,A	167,60	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	645	2988	porB1b	1035	630	97.3	porB1b.l15.c30.ctg.1	834	199.6	0	HET	.	.	.	A392T	.	392	392	A	596	596	A	230	A,T	135,78	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	645	2988	porB1b	1035	630	97.3	porB1b.l15.c30.ctg.1	834	199.6	0	HET	.	.	.	G400A	.	400	400	G	604	604	G	227	G,A	147,65	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	645	2988	porB1b	1035	630	97.3	porB1b.l15.c30.ctg.1	834	199.6	0	HET	.	.	.	G402T	.	402	402	G	606	606	G	231	G,T	150,64	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	645	2988	porB1b	1035	630	97.3	porB1b.l15.c30.ctg.1	834	199.6	0	HET	.	.	.	T403G	.	403	403	T	607	607	T	233	T,G	147,65	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	645	2988	porB1b	1035	630	97.3	porB1b.l15.c30.ctg.1	834	199.6	0	HET	.	.	.	T405G	.	405	405	T	609	609	T	234	T,G	147,64	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	645	2988	porB1b	1035	630	97.3	porB1b.l15.c30.ctg.1	834	199.6	0	HET	.	.	.	T160G	.	160	160	T	364	364	T	270	T,G	156,95	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	645	2988	porB1b	1035	630	97.3	porB1b.l15.c30.ctg.1	834	199.6	0	HET	.	.	.	A418G	.	418	418	A	622	622	A	238	A,G	135,83	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	645	2988	porB1b	1035	630	97.3	porB1b.l15.c30.ctg.1	834	199.6	0	HET	.	.	.	A419G	.	419	419	A	623	623	A	237	A,G	133,83	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	645	2988	porB1b	1035	373	91.43	porB1b.l15.c30.ctg.2	385	58.6	0	.	p	.	0	R187Q	NONSYN	559	561	CGA	22	24	CAA	31;31;30	C;A;A	12;12;12	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	645	2988	porB1b	1035	373	91.43	porB1b.l15.c30.ctg.2	385	58.6	0	.	p	.	0	G189S	NONSYN	565	567	GGC	28	30	AGC	32;32;32	A;G;C	15;15;15	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	645	2988	porB1b	1035	373	91.43	porB1b.l15.c30.ctg.2	385	58.6	0	.	p	.	0	I209M	NONSYN	625	627	ATC	88	90	ATG	58;58;56	A;T;G,C	48;48;0,47	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	645	2988	porB1b	1035	373	91.43	porB1b.l15.c30.ctg.2	385	58.6	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	94	94	T	60	T	52	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	645	2988	porB1b	1035	212	97.64	porB1b.l15.c30.ctg.3	245	184.4	0	.	p	.	0	S288T	NONSYN	862	864	TCT	39	41	ACT	127;126;129	A;C;T	76;76;80	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	645	2988	porB1b	1035	212	97.64	porB1b.l15.c30.ctg.3	245	184.4	0	.	p	.	0	H290D	NONSYN	868	870	CAT	45	47	GAT	128;129;130	G;A;T	82;85;88	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	645	2988	porB1b	1035	212	97.64	porB1b.l15.c30.ctg.3	245	184.4	0	.	p	.	0	D293N	NONSYN	877	879	GAC	54	56	AAC	134;136;143	A;A;C	97;97;102	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	645	2988	porB1b	1035	212	97.64	porB1b.l15.c30.ctg.3	245	184.4	0	.	p	.	0	Y294H	NONSYN	880	882	TAC	57	59	CAC	145;144;143	C;A;C	104;103;103	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	645	2988	porB1b	1035	212	97.64	porB1b.l15.c30.ctg.3	245	184.4	0	.	p	.	0	E329D	NONSYN	985	987	GAA	162	164	GAC	264;266;266	G,A;A;C	237,1;241;243	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	645	2988	porB1b	1035	389	92.52	porB1b.l15.c30.ctg.4	401	90.8	0	.	p	.	0	R187Q	NONSYN	559	561	CGA	28	30	CAA	60;60;60	C;A;A	25;25;25	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	645	2988	porB1b	1035	389	92.52	porB1b.l15.c30.ctg.4	401	90.8	0	.	p	.	0	G189S	NONSYN	565	567	GGC	34	36	AGC	64;65;66	A;G;C	30;31;32	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	645	2988	porB1b	1035	389	92.52	porB1b.l15.c30.ctg.4	401	90.8	0	.	p	.	0	I209M	NONSYN	625	627	ATC	94	96	ATG	95;96;99	A;T;G	84;83;85	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	645	2988	porB1b	1035	389	92.52	porB1b.l15.c30.ctg.4	401	90.8	0	.	p	.	0	E210_Y211insR	INS	628	628	G	97	97	G	101	G	88	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	645	2988	porB1b	1035	389	92.52	porB1b.l15.c30.ctg.4	401	90.8	0	.	p	.	0	.	MULTIPLE	632	633	AC	105	107	TTT	106;102;101	T;T;T	96;94;94	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	645	2988	porB1b	1035	389	92.52	porB1b.l15.c30.ctg.4	401	90.8	0	.	p	.	0	N212fs	FSHIFT	634	634	A	109	109	T	102	T	95	.	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	667	11442	rpoB	4179	4179	99.98	rpoB.l6.c30.ctg.1	4778	238.6	0	.	p	.	0	R364W	NONSYN	1090	1092	CGG	1295	1297	TGG	278;279;280	T,C;G;G	162,97;261;264	.	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	667	11442	rpoB	4179	4179	99.98	rpoB.l6.c30.ctg.1	4778	238.6	1	SNP	p	H553N	0	.	.	1657	1659	CAT	1862	1864	CAT	257;256;255	C,A;A;T	240,1;236;238	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	667	11442	rpoB	4179	4179	99.98	rpoB.l6.c30.ctg.1	4778	238.6	0	HET	.	.	.	C3117T	.	3117	3117	C	3322	3322	C	258	C,T	166,69	.	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	667	11442	rpoB	4179	4179	99.98	rpoB.l6.c30.ctg.1	4778	238.6	0	HET	.	.	.	C3042T	.	3042	3042	C	3247	3247	C	280	C,T	176,74	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	155	1216	rpsJ	312	312	100.0	rpsJ.l15.c17.ctg.1	993	121.1	1	SNP	p	V57M	1	.	.	169	171	ATG	454	456	ATG	270;273;274	A,G;T;G	104,147;253;256	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	2740	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2543	107.4	0	.	p	.	0	M177T	NONSYN	529	531	ATG	897	899	ACG	88;86;87	A;C;G	83;83;83	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	2740	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2543	107.4	0	.	p	.	0	Y184D	NONSYN	550	552	TAC	918	920	GAC	79;77;77	G;A;C	79;76;76	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	2740	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2543	107.4	0	.	p	.	0	T190M	NONSYN	568	570	ACG	936	938	ATG	78;77;77	A;T;G	78;76;77	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	2740	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2543	107.4	0	.	p	.	0	L194S	NONSYN	580	582	TTA	948	950	TCA	75;75;77	T;C;A	75;74;76	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	2740	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2543	107.4	0	.	p	.	0	H209Q	NONSYN	625	627	CAT	993	995	CAG	75;78;79	C;A;G	74;77;78	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	2740	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2543	107.4	0	.	p	.	0	V216L	NONSYN	646	648	GTT	1014	1016	CTT	69;70;70	C;T;T	69;70;70	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	2740	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2543	107.4	0	.	p	.	0	N223S	NONSYN	667	669	AAC	1035	1037	AGT	77;74;73	A;G;T	76;73;71	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	2740	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2543	107.4	0	.	p	.	0	Q246P	NONSYN	736	738	CAG	1104	1106	CCG	106;111;113	C;C;G	95;101;102	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	2740	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2543	107.4	0	.	p	.	0	P280S	NONSYN	838	840	CCG	1206	1208	TCG	153;154;154	T;C;G	139;140;138	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	2740	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2543	107.4	0	.	p	.	0	E337K	NONSYN	1009	1011	GAG	1377	1379	AAA	75;73;73	A;A;A	74;72;72	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	2740	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2543	107.4	0	.	p	.	0	R338K	NONSYN	1012	1014	AGA	1380	1382	AAG	72;70;69	A;A;G	71;69;68	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	2740	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2543	107.4	0	.	p	.	0	L343H	NONSYN	1027	1029	CTC	1395	1397	CAC	59;59;58	C;A;C	59;58;58	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	2740	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2543	107.4	0	.	p	.	0	Q356E	NONSYN	1066	1068	CAA	1434	1436	GAA	59;57;58	G;A;A	59;57;58	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	2740	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2543	107.4	0	.	p	.	0	A382T	NONSYN	1144	1146	GCG	1512	1514	ACG	37;37;39	A;C;G	37;37;38	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	2740	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2543	107.4	0	.	p	.	0	T399I	NONSYN	1195	1197	ACT	1563	1565	ATT	64;64;64	A;T;T	63;63;63	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	2740	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2543	107.4	0	.	p	.	0	C400S	NONSYN	1198	1200	TGT	1566	1568	AGT	64;62;61	A;G;T	63;61;60	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	2740	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2543	107.4	0	.	p	.	0	I413L	NONSYN	1237	1239	ATA	1605	1607	CTA	77;78;79	C,A;T;A	70,1;73;74	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	2740	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2543	107.4	0	.	p	.	0	K427N	NONSYN	1279	1281	AAA	1647	1649	AAT	55;54;54	A;A;T,A	52;51;50,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	2740	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2543	107.4	0	.	p	.	0	A450S	NONSYN	1348	1350	GCA	1716	1718	TCA	85;85;85	T,G;C,A;A	83,1;83,1;84	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	2740	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2543	107.4	0	.	p	.	0	V458M	NONSYN	1372	1374	GTA	1740	1742	ATG	86;86;87	A;T;G	84;84;85	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	2740	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2543	107.4	0	.	p	.	0	N556T	NONSYN	1666	1668	AAC	2034	2036	ACC	171;170;170	A;C;C	156;156;155	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	2740	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2543	107.4	0	.	p	.	0	K588E	NONSYN	1762	1764	AAA	2130	2132	GAA	173;170;171	G;A;A	163;160;162	.	Tetracycline resistance
